137 related articles for article (PubMed ID: 11981592)
1. Metabolic mapping of the time-dependent effects of delta 9-tetrahydrocannabinol administration in the rat.
Whitlow CT; Freedland CS; Porrino LJ
Psychopharmacology (Berl); 2002 May; 161(2):129-36. PubMed ID: 11981592
[TBL] [Abstract][Full Text] [Related]
2. Behavioural sensitization after repeated exposure to Delta 9-tetrahydrocannabinol and cross-sensitization with morphine.
Cadoni C; Pisanu A; Solinas M; Acquas E; Di Chiara G
Psychopharmacology (Berl); 2001 Nov; 158(3):259-66. PubMed ID: 11713615
[TBL] [Abstract][Full Text] [Related]
3. Repeated exposure to Delta(9)-tetrahydrocannabinol alters heroin-induced locomotor sensitisation and Fos-immunoreactivity.
Singh ME; McGregor IS; Mallet PE
Neuropharmacology; 2005 Dec; 49(8):1189-200. PubMed ID: 16137723
[TBL] [Abstract][Full Text] [Related]
4. Functional consequences of the repeated administration of Delta9-tetrahydrocannabinol in the rat.
Whitlow CT; Freedland CS; Porrino LJ
Drug Alcohol Depend; 2003 Aug; 71(2):169-77. PubMed ID: 12927655
[TBL] [Abstract][Full Text] [Related]
5. I. Functional consequences of intragastrically administered ethanol in rats as measured by the 2-[14C]deoxyglucose method.
Williams-Hemby L; Porrino LJ
Alcohol Clin Exp Res; 1997 Dec; 21(9):1573-80. PubMed ID: 9438515
[TBL] [Abstract][Full Text] [Related]
6. Dose and behavioral context dependent inhibition of movement and basal ganglia neural activity by Delta-9-tetrahydrocannabinol during spontaneous and treadmill locomotion tasks in rats.
Shi LH; Luo F; Woodward DJ; Chang JY
Synapse; 2005 Jan; 55(1):1-16. PubMed ID: 15499609
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic factors in sex differences in Delta 9-tetrahydrocannabinol-induced behavioral effects in rats.
Tseng AH; Harding JW; Craft RM
Behav Brain Res; 2004 Sep; 154(1):77-83. PubMed ID: 15302113
[TBL] [Abstract][Full Text] [Related]
8. Chronic treatment with Delta-9-tetrahydrocannabinol alters the structure of neurons in the nucleus accumbens shell and medial prefrontal cortex of rats.
Kolb B; Gorny G; Limebeer CL; Parker LA
Synapse; 2006 Nov; 60(6):429-36. PubMed ID: 16881072
[TBL] [Abstract][Full Text] [Related]
9. Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users.
Curran HV; Brignell C; Fletcher S; Middleton P; Henry J
Psychopharmacology (Berl); 2002 Oct; 164(1):61-70. PubMed ID: 12373420
[TBL] [Abstract][Full Text] [Related]
10. Gonadal hormone modulation of the behavioral effects of Delta9-tetrahydrocannabinol in male and female rats.
Craft RM; Leitl MD
Eur J Pharmacol; 2008 Jan; 578(1):37-42. PubMed ID: 17905227
[TBL] [Abstract][Full Text] [Related]
11. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
[TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of 1-Trans-Delta(9)-Tetrahydrocannabinol (CAS No. 1972-08-3) in F344 Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Nov; 446():1-317. PubMed ID: 12594529
[TBL] [Abstract][Full Text] [Related]
13. The time-dependent effects of midazolam on regional cerebral glucose metabolism in rats.
Freo U; Dam M; Ori C
Anesth Analg; 2008 May; 106(5):1516-23, table of contents. PubMed ID: 18420870
[TBL] [Abstract][Full Text] [Related]
14. In vivo up-regulation of brain-derived neurotrophic factor in specific brain areas by chronic exposure to Delta-tetrahydrocannabinol.
Butovsky E; Juknat A; Goncharov I; Elbaz J; Eilam R; Zangen A; Vogel Z
J Neurochem; 2005 May; 93(4):802-11. PubMed ID: 15857384
[TBL] [Abstract][Full Text] [Related]
15. Dose-dependent effects of Delta9-tetrahydrocannabinol on rates of local cerebral glucose utilization in rat.
Freedland CS; Whitlow CT; Miller MD; Porrino LJ
Synapse; 2002 Aug; 45(2):134-42. PubMed ID: 12112406
[TBL] [Abstract][Full Text] [Related]
16. Decreased basal endogenous opioid levels in diabetic rodents: effects on morphine and delta-9-tetrahydrocannabinoid-induced antinociception.
Williams J; Haller VL; Stevens DL; Welch SP
Eur J Pharmacol; 2008 Apr; 584(1):78-86. PubMed ID: 18313663
[TBL] [Abstract][Full Text] [Related]
17. Sex differences in the effects of delta9-tetrahydrocannabinol on spatial learning in adolescent and adult rats.
Cha YM; Jones KH; Kuhn CM; Wilson WA; Swartzwelder HS
Behav Pharmacol; 2007 Sep; 18(5-6):563-9. PubMed ID: 17762524
[TBL] [Abstract][Full Text] [Related]
18. Pre- and post-conditioning treatment with an ultra-low dose of Δ9-tetrahydrocannabinol (THC) protects against pentylenetetrazole (PTZ)-induced cognitive damage.
Assaf F; Fishbein M; Gafni M; Keren O; Sarne Y
Behav Brain Res; 2011 Jun; 220(1):194-201. PubMed ID: 21315768
[TBL] [Abstract][Full Text] [Related]
19. Behavioral sensitization to delta 9-tetrahydrocannabinol and cross-sensitization with morphine: differential changes in accumbal shell and core dopamine transmission.
Cadoni C; Valentini V; Di Chiara G
J Neurochem; 2008 Aug; 106(4):1586-93. PubMed ID: 18513369
[TBL] [Abstract][Full Text] [Related]
20. Acute delta9-tetrahydrocannabinol exposure facilitates quinpirole-induced hyperlocomotion.
Gorriti MA; Ferrer B; del Arco I; Bermúdez-Silva FJ; de Diego Y; Fernandez-Espejo E; Navarro M; Rodríguez de Fonseca F
Pharmacol Biochem Behav; 2005 May; 81(1):71-7. PubMed ID: 15894066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
